Akero Therapeutics Inc buy Cantor Fitzgerald
Start price
11.10.23
/
50%
€13.80
Target price
11.10.24
€36.75
Performance (%)
89.20%
Price
25.07.24
€26.11
Summary
This prediction is currently active. The BUY prediction by Cantor_Fitzgerald for Akero Therapeutics Inc has seen massive gains of 89.20%. This prediction currently runs until 11.10.24. The prediction end date can be changed by Cantor_Fitzgerald at any time. Cantor_Fitzgerald has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Akero Therapeutics Inc | 5.070% | 5.070% |
| iShares Core DAX® | 1.280% | 1.320% |
| iShares Nasdaq 100 | -2.457% | -5.192% |
| iShares Nikkei 225® | -2.006% | -1.389% |
| iShares S&P 500 | -0.662% | -1.884% |
Comments by Cantor_Fitzgerald for this prediction
In the thread Akero Therapeutics Inc diskutieren
Akero Therapeutics, Inc. (NASDAQ: AKRO) had its price target lowered by analysts at Cantor Fitzgerald from $69.00 to $39.00. They now have an "overweight" rating on the stock.
Ratings data for AKRO provided by MarketBeat
Stopped prediction by Cantor_Fitzgerald for Akero Therapeutics Inc
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€20.34
20.06.24
20.06.24
-
20.06.25
20.06.25
28.37%
25.07.24
25.07.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€23.57
12.06.24
12.06.24
-
12.06.25
12.06.25
10.78%
25.07.24
25.07.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€43.60
04.10.23
04.10.23
€65.81
04.10.24
04.10.24
-43.60%
25.07.24
25.07.24
Akero Therapeutics Inc
Start price
Target price
Perf. (%)
€48.20
19.09.23
19.09.23
€64.47
19.09.24
19.09.24
-48.98%
25.07.24
25.07.24